Following Dexcom’s recent “Terms Update Debacle”, Diabettech took a a deep dive into what happened, what it means, and whether some of the content of recent updates to terms run counter to the overarching rules about personal health data in various jurisdictions.
9 sensors; 15 days; 150 fingerpricks. The results of the “nine sensor samba” are in, and they’re not what we were expecting…
Previewing the “Nine Sensor Samba”: Our real-world comparison of nine CGMs simultaneously, assessing accuracy (MARD), Time-in-Range, lag, and app usability.
As we discussed in the first article in this series, there’s a lot of marketing about having More with your CGM, whether that’s accuracy or […]
With performance numbers on the new 15-day, prescription free, Stelo sensor from Dexcom looking very similar to those from the G7, could Dexcom be contemplating the announcement of an uldated 15-day iCGM at EASD in Madrid?
As many people will have seen, Dexcom have been expanding their product line based on the G7 hardware. The replacement for their more budget device, […]
In the past at Diabettech, we’ve talked about how the design of a CGM safety and accuracy study plays a big part in the results […]
Late in 2023, I received two Medtrum Nano sensors to try out, given to me by Medtrum. Historically, I’ve found that their CGM products have […]
Having tested a G7 against the Libre3, and found that without calibration, it tended to produce results that I wasn’t satisfied with using just the […]
As I’ve previously discussed, I’ve been running a side by side trial of the currently available CGM systems in the UK. It focused on those […]
Copyright © 2026 | WordPress Theme by MH Themes